Keywords: smithkline, beecham, 3rd, qtr, earnings, leap, fueled

SmithKline Beecham 3rd Qtr Earnings Leap 20%

Article | 28 October 1996

Fueled by new products and a strong performance in the USA (up 33%), Anglo-American drugmaker SmithKline Beecham reported third-quarter 1996 sales up 15% ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Carvedilol

Relafen

Nabumetone

Requip

Ropinirole Hcl

Go to drug listing